
Work with us
ANSTO drives Australian innovation through partnerships designed to respond to the needs of industry. Get in touch to discuss business opportunities today.
Showing 21 - 40 of 672 results
ANSTO drives Australian innovation through partnerships designed to respond to the needs of industry. Get in touch to discuss business opportunities today.
Since 1962, the United Uranium Scholarship has helped promising young scientists in the field of nuclear energy extend their knowledge and expertise. In 2022, scholarships were awarded to several ANSTO researchers, including Phil Sutton.
With the support of the Sir William Tyree Foundation, ANSTO is offering two career development opportunities for young Indigenous Australians in the area of work, health and safety.
Ongoing media statements relating to nuclear medicine production.
ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.
ANSTO is working with government partners to ensure that radioactivity in drinking water supplied to Aboriginal communities is at levels considered safe for consumption.
ANSTO researchers are undertaking the fabrication and characterising advanced fuels and investigating the key properties of nuclear waste and its long-term interaction with containment materials to improve safety for short and long-term storage.
ANSTO is proud to support calls for daring and innovative ideas to fight COVID-19 as part of the ACS online Flatten The Curve hackathon.
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
ANSTO has a range of capabilities and expertise to support aerospace and space research.
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
ANSTO physicist supports launch of new carbon ion therapy treatment service in Austria.